In summary, we used the widely accepted IVs for ADAMTS13 and the summary data from GWAS reports to demonstrate that ADAMTS13 activity was not associated with ischemic stroke risk in the general population. This evidence concerns the gene ADAMTS13 and ischemic stroke.